Doctor Maurizio Landolina
Maggiore Hospital of Crema, Crema (Italy)
Membership:
FESC Member
EHRA Member
Follow
Contributor content
Presentation
Presentation
Ventricular pacing percentage and atrial fibrillation risk in dual chamber cardiac implantable devices.
Presentation
Use of anti-arrhythmic drug therapy following cryoballoon ablation of paroxysmal atrial fibrillation does not lead to improved clinical outcome. Data from a multicenter observational project.
Presentation
Use of anti-arrhythmic drug therapy in patients treated with Cryoballoon pulmonary vein isolation for paroxysmal atrial fibrillation: data from a multicenter observational project
Presentation
In CRT-D patients reverse remodeling and occurrence of VT/VF episodes, but not defibrillator therapies, are determinants of death or HF hospitalization risk.
Presentation
Procedural data, peri-procedural complications and long term outcomes of cryoballoon ablation of paroxysmal atrial fibrillation: the influence of center expertise (high volume vs low volume)
Presentation
Left ventricular reverse remodeling by cardiac resynchronization is associated with lower risk of ventricular tachyarrhythmias
Presentation
The economic impact of longevity of implantable cardioverter-defibrillator for cardiac resynchronization therapy from a healthcare service perspective
Presentation
